Kahn, Jonathan <br/><br/>
Being specific about race-specific medicine.  [electronic resource] 

 -  Health affairs (Project Hope)   
 - w375-7 p.  digital 
<br/><br/> Publication Type: Comment; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>2694-233X 
<br/><br/><label>Standard No.: </label>10.1377/hlthaff.25.w375  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Black or African American--genetics<br/>Drug Approval<br/>Drug Combinations<br/>Drug Industry<br/>Genetic Predisposition to Disease--ethnology<br/>Heart Failure--drug therapy<br/>Humans<br/>Hydralazine<br/>Isosorbide Dinitrate--therapeutic use<br/>Risk<br/>United States<br/>United States Food and Drug Administration<br/>Vasodilator Agents--therapeutic use